Trial · NCT04371666
Participant flow16
How many started, completed or left each group, period by period.
1 to 16 of 16
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| DB Treatment Period (52 Weeks) | STARTED | Pamrevlumab | 49 | |
| DB Treatment Period (52 Weeks) | STARTED | Placebo | 49 | |
| DB Treatment Period (52 Weeks) | Received at Least 1 Dose of Study Drug | Pamrevlumab | 48 | |
| DB Treatment Period (52 Weeks) | Received at Least 1 Dose of Study Drug | Placebo | 49 | |
| DB Treatment Period (52 Weeks) | COMPLETED | Pamrevlumab | 44 | |
| DB Treatment Period (52 Weeks) | COMPLETED | Placebo | 46 | |
| DB Treatment Period (52 Weeks) | NOT COMPLETED | Pamrevlumab | 5 | |
| DB Treatment Period (52 Weeks) | NOT COMPLETED | Placebo | 3 | |
| OLE (Maximum Exposure: 93.4 Weeks) | STARTED | Pamrevlumab | 43 | |
| OLE (Maximum Exposure: 93.4 Weeks) | STARTED | Placebo | 43 | |
| OLE (Maximum Exposure: 93.4 Weeks) | Received at Least 1 Dose of Study Drug | Pamrevlumab | 43 | |
| OLE (Maximum Exposure: 93.4 Weeks) | Received at Least 1 Dose of Study Drug | Placebo | 43 | |
| OLE (Maximum Exposure: 93.4 Weeks) | COMPLETED | Pamrevlumab | 0 | |
| OLE (Maximum Exposure: 93.4 Weeks) | COMPLETED | Placebo | 0 | |
| OLE (Maximum Exposure: 93.4 Weeks) | NOT COMPLETED | Pamrevlumab | 43 | |
| OLE (Maximum Exposure: 93.4 Weeks) | NOT COMPLETED | Placebo | 43 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04371666/flow